| Literature DB >> 35283783 |
Zeljka Minic1,2, Donal S O'Leary3, Christian A Reynolds1,2.
Abstract
The spinal cord is an important integrative center for blood pressure control. Spinal sensory fibers send projections to sympathetic preganglionic neurons of the thoracic spinal cord and drive sympathetically-mediated increases in blood pressure. While these reflexes responses occur in able-bodied individuals, they are exaggerated following interruption of descending control - such as occurs following spinal cord injury. Similar reflex control of blood pressure may exist in disease states, other than spinal cord injury, where there is altered input to sympathetic preganglionic neurons. This review primarily focuses on mechanisms wherein visceral afferent information traveling via spinal nerves influences sympathetic nerve activity and blood pressure. There is an abundance of evidence for the widespread presence of this spinal reflex arch originating from virtually every visceral organ and thus having a substantial role in blood pressure control. Additionally, this review highlights specific endogenous eicosanoid species, which modulate the activity of afferent fibers involved in this reflex, through their interactions with transient receptor potential (TRP) cation channels.Entities:
Keywords: blood pressure (BP); eicosanoids in physiological and pathological processes; spinal cord injury; sympathetic nerve activity (SNA); transient receptor potential (TRP) channel; visceral reflexes
Year: 2022 PMID: 35283783 PMCID: PMC8904930 DOI: 10.3389/fphys.2022.838175
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Neural circuitry regulating sympathetic nerve activity. Major excitatory drive to sympathetic preganglionic neurons arises from the rostral ventrolateral medulla. Additional excitatory input from propriospinal projecting neurons is buffered by descending inhibitory drive arising above the level of the superior colliculus.
Eicosanoid metabolites activating TRP Channels.
| Precursor PUFA | Eicosanoid lipid mediator | TPR channel interaction(s) | Reference(s) |
| Linoleic acid | ● 13-hydroxy-9Z,11E-octadecadienoic acid (13-HODE) | TRPA1, TRPV1, TRPV2, agonist | |
| ● 13-oxo-9Z,11E-octadecadienoic acid (13-oxo-HODE) | TRPV1 agonist | ||
| ● 9-hydroxy-10E,12Z-octadecadienoic acid (9-HODE) | TRPA1, TRPV1 agonist | ||
| ● 9-ox0-10E,12Z-octadecadienoic acid (9-oxo-HODE) | TRPV1 agonist | ||
| ● 9,10-dihydroxy-12Z-octadecenoic acid (9,10-DiHOME) | TRPA1, TRPV1 agonist | ||
| ● 9,10-epoxy-12Z-octadecenoic acid (9(10)EpOME) | TRPA1, TRPV1 agonist | ||
| ● 12,13-dihydroxy-9Z-octadecenoic acid (12,13-DiHOME) | TRPA1, TRPV1 agonist | ||
| ● 12(13)epoxy-9Z-octadecenoic acid (12(13)EpOME) | TRPA1, TRPV1 agonist | ||
| Arachidonic acid | ● 5,6-epoxy-8Z,11Z,14Z-eicosatrienoic acid (5,6-EET) | TRPA1, TRPV4 agonist | |
| ● 8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid (8,9-EET) | TRPA1, TRPV4 agonist |
| |
| ● Prostaglandin A1 (PGA1) | TPPA1 agonist |
| |
| ● Prostaglandin A2 (PGA2) | TPPA1 agonist |
| |
| ● 8-iso Prostaglandin A2 (8-iso-PGA2) | TRPA1 agonist |
| |
| ● 12S-hydroperoxy-5Z,8Z,10E,14Z-eicosatetraenoic acid (12-HpETE) | TRPV1 agonist |
| |
| ● 15S-hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid (15-HpETE) | TRPV1 agonist |
| |
| ● 5S-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-HETE) | TRPV1 agonist |
| |
| ● Leukotriene B4 (LTB4) | TRPV1 agonist |
|
FIGURE 2The figure illustrates evoked afferent nerve activity as a factor of stimulus intensity. Following sensitization (e.g., TRP-Eicosanoid binding), the activation threshold (intersection of a curve with the X -axis) is reduced. Similarly, the magnitude of the afferent response to a given stimulus is increased.